home / Japan / KYORIN Pharmaceutical

KYORIN Pharmaceutical Market Cap

$0.53 B

-1.48 M

TSE:4569.T · January 22, 2025

Share price

$9.26

Enterprise Value

$92.96 B

Change (1-Year)

-16.7%

Global Rank

#6038

Country Rank

#285

Regions

Japan

Market cap

As of January 22, 2025, KYORIN Pharmaceutical (4569.T) has a market cap of $0.53 billion USD. According to our data, KYORIN Pharmaceutical is ranked No.6038 in global market value.

Sector Rank:

Biotech #339 Pharmaceuticals #310

4569.T Market Capitalization Growth

30D Growth:

-0.62%

1 Years Growth:

-16.7%

3 Years Growth:

-14.1%

5 Years Growth:

-14.6%

10 Years Growth:

-15.4%

15 Years Growth:

66.9%

20 Years Growth:

57.2%

Total Growth:

-10%

KYORIN Pharmaceutical Market Cap Chart

YTD

10Y

15Y

20Y

MAX

KYORIN Pharmaceutical Market Cap CAGR Chart

KYORIN Pharmaceutical Market Cap History 2001 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$0.53 B	-4.32%
Dec 30, 2024	$0.56 B	-12.85%
Dec 29, 2023	$0.64 B	6.59%
Dec 30, 2022	$0.60 B	-4.12%
Dec 30, 2021	$0.62 B	-1.64%
Dec 30, 2020	$0.63 B	5.28%
Dec 30, 2019	$0.60 B	-17.54%
Dec 31, 2018	$0.73 B	17.26%
Dec 29, 2017	$0.62 B	-13.65%
Dec 30, 2016	$0.72 B	1.60%
Dec 30, 2015	$0.71 B	15.64%
Dec 30, 2014	$0.61 B	2.23%
Dec 30, 2013	$0.60 B	37.42%
Dec 28, 2012	$0.44 B	27.19%
Dec 30, 2011	$0.34 B	-1.60%
Dec 30, 2010	$0.35 B	8.09%
Dec 30, 2009	$0.32 B	8.19%
Dec 30, 2008	$0.30 B	5.73%
Dec 28, 2007	$0.28 B	-10.47%
Dec 29, 2006	$0.32 B	0.28%
Dec 30, 2005	$0.31 B	-10.20%
Dec 31, 2004	$0.35 B	29.38%
Dec 31, 2003	$0.27 B	-31.18%
Dec 31, 2002	$0.39 B	-48.50%
Dec 31, 2001	$0.76 B	100%

Similar Companies to KYORIN Pharmaceutical

Name	Market Cap	Market cap difference	Regions
Eli Lilly LLY	$677.80 B	-0.006 M	USA
Novo Nordisk A/S NOVO-B.CO	$365.09 B	95.523 B	Denmark
Johnson & Johnson JNJ	$349.71 B	-0.006 M	USA
Novo Nordisk NVO	$335.32 B	64.114 B	Denmark
AbbVie ABBV	$298.91 B	0.013 M	USA
Roche ROG.SW	$243.91 B	38.073 B	Switzerland
Merck MRK	$242.01 B	0.005 M	USA
Thermo Fisher Scientific TMO	$219.73 B	0.006 M	USA
AstraZeneca AZN	$211.49 B	0.007 M	UK
Novartis NVS	$196.25 B	0.003 M	Switzerland
Pfizer PFE	$147.43 B	0.004 M	USA
Amgen AMGN	$146.98 B	0.004 M	USA
Sanofi SNY	$129.14 B	0.001 M	France
Gilead Sciences GILD	$115.95 B	0.002 M	USA
Bristol-Myers Squibb BMY	$115.77 B	0.000 M	USA
Vertex Pharmaceuticals VRTX	$110.22 B	0.001 M	USA
CSL CSL.AX	$82.06 B	-0.963 B	Australia
Zoetis ZTS	$75.17 B	-0.004 M	USA
Regeneron Pharmaceuticals REGN	$74.73 B	1.236 B	USA
Chugai Pharmaceutical 4519.T	$69.96 B	0.455 B	Japan

About KYORIN Pharmaceutical Inc.

Name

KYORIN PHARMACEUTICAL CO LTD

Website

https://www.kyorin-pharm.co.jp

Headquarters

Tokyo,None

symbol

4569.T

CURRENCY

JPY

country

Japan

fullTimeEmployees

2042

exchange

JPX

firstTradeDateEpochUtc

2001/01/04

4569.T Market Cap Formula

Market Cap	=	4569.T Stock Price	*	4569.T Shares Outstanding
	=	$9.26	*	57.45 M
	=	$0.53 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe